Audubon, PA, October 23, 2012: Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced it will be showcasing several new products at the North American Spine Society (NASS) Annual Meeting, being held October 24-26 in Dallas, Texas, at their exhibit Booth #1717.
SECURE®-C Cervical Artificial Disc
The SECURE®-C is a motion-sparing technology designed as an alternative to fusion. Its innovative design allows for controlled translation in flexion-extension which was confirmed by clinical findings and is the only device on the market with a lordotic option. At 24 months post-operative, the 380 patient study showed statistical superiority over the control, anterior cervical discectomy and fusion (ACDF), in overall success, rate of surgical intervention, and patient satisfaction. In addition, SECURE®-C patients had a lower rate of adjacent level surgery compared to ACDF.
Neurosurgeon Joseph Marzluff, MD, stated, “SECURE®-C is truly unique among the field of cervical artificial discs. The specific design allows a more natural movement of the vertebral bodies. The innovation and design of the surgical instruments and procedure developed by Globus provides a simple, safe and easy implantation for the patient.”
SI-LOK® Sacroiliac Fixation System
The SI-LOK® System is a comprehensive set of hydroxyapatite (HA) coated screws, cannulated drill bits and wires specifically designed for a lateral approach to the sacroiliac (SI) joint. The system offers the security of a fully threaded connection, the strength of a large diameter screw, and optional graft slot designed to promote fusion.
RISE™ IntraLIF™ Expandable Interbody
RISE™ is an innovative titanium expandable lumbar fusion device that achieves traditional fusion goals through an 8.5mm corridor. By leveraging endoscopic access and visualization through the IntraLIF™ procedure, RISE™ can be expanded in situ to distract and optimize fit. The RISE™ implant coupled with the IntraLIF™ procedure further minimizes anatomical disruption over traditional MIS techniques. The IntraLIF™ procedure preserves the facet joint by accessing the disc from a posterior approach, lateral to the facets, with less disruptive dilation methods. This approach optimizes disc access and improves implant placement.
REVERE® 4.5 Stabilization System
The REVERE® 4.5 System is a smaller sized posterior fixation line extension from our current REVERE® Stabilization System that consists of rods, hooks, polyaxial screws, locking caps, t-connectors, staples and associated surgical instruments. This system is indicated for use in both pediatric and skeletally mature small stature patients. The system was designed to treat complex spinal deformities and as an adjunct to fusion for adolescent idiopathic scoliosis. Based on the success of the REVERE® pedicle screw line, the same non-threaded locking cap eliminates cross threading, screws and hooks provide strong bone purchase, and the system offers multiple options through the use of intuitively designed, ergonomic instruments.
PLYMOUTH™ Thoracolumbar Plate System
The newest product in Globus’ growing LLIF solutions portfolio, Plymouth™ is a single incision minimally invasive surgical (MIS) plate stabilization system for thoracolumbar interbody fusion. The PLYMOUTH™ MIS Lateral Plate System and keying instrumentation precisely align the plate with the interbody device and vertebral body endplates, allowing controlled placement and minimal retraction. With Globus’ MARS™ 3V retractor system, the PLYMOUTH™ system is designed to work optimally with the full suite of Globus’ LLIF and MIS products, including the TransContinental® spacer, InterContinental® lateral plate and spacer, and the expanding interbody spacers CALIBER® and CALIBER®-L.
FORTIFY® is an adjustable corpectomy spacer that streamlines vertebral body replacement and provides a multitude of options designed to restore height, alignment and stability. FORTIFY® is available in a wide variety of footprints, heights and lordotic/kyphotic angles, and can be implanted through a variety of approaches. In addition, FORTIFY® provides one step insertion and expansion with automatic locking to simplify the technique. PEEK or titanium materials, maximized expansion ranges, and modular endplates allow surgeons to optimize fit for each patient.
More information on these as well as Globus’ full portfolio of products can be found at www.globusmedical.com.
In addition to their full line of spinal implant solutions on display, Globus will be hosting presentations and training on select new products, including SECURE®-C, SI-LOK®, and their suite of Lateral Lumbar Interbody Fusion (LLIF) solutions:
Wednesday, October 24th
12:15 PM 1:00 PM SI-LOK® Presentation, Globus Booth, #1717
3:30 PM 4:00 PM SECURE®–C Presentation, Globus Booth, #1717
Thursday, October 25th
10:05 AM 10:30 AM SI-LOK® Presentation, Globus Booth, #1717
11:00 AM 12:30 PM SI-LOK® Mobile Lab, Booth #3209
12:15 AM 1:00 PM SECURE®–C Presentation, Globus Booth, #1717
3:25 PM 3:55 PM LLIF Presentation, Globus Booth, #1717
About Globus Medical, Inc.
Globus Medical, Inc. is a leading spinal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of terms such as anticipate, believe, could, estimate, expect, intend, may, plan, predict, project, will, and other similar terms. These forward-looking statements are based on our current assumptions, knowledge, beliefs, estimates, expectations and views. These forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that are difficult to predict and may affect our businesses and operations. As a result, our actual results may differ materially and adversely from those expressed or implied by our forward-looking statements. As a result, you should not place undue reliance on any of these forward-looking statements. For a discussion of some of the risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our prospectus filed with the Securities and Exchange Commission on August 3, 2012, as amended, including the sections labeled “Risk Factors,” “Cautionary Note Concerning Forward-Looking Statements,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in our periodic reports on file with the Securities and Exchange Commission. These documents are available at www.sec.gov. We undertake no obligation to update any forward-looking statements as a result of new information or future events or circumstances arising after the date on which it was made. Moreover, we operate in an evolving environment. Additional risks, uncertainties and other factors emerge from time to time and it is not possible for us to predict all risks, uncertainties and other factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.